Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.50
-$0.15-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 72.44% | 38.14% | 198.01% | 33.69% | 28.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.11% | 38.53% | 90.83% | 1.16% | -10.36% |
| Operating Income | -113.11% | -38.53% | -90.83% | -1.16% | 10.36% |
| Income Before Tax | -76.37% | 2.56% | -111.07% | 7.01% | -77.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -76.37% | 2.56% | -111.07% | 7.01% | -77.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.37% | 2.56% | -111.07% | 7.01% | -77.52% |
| EBIT | -113.11% | -38.53% | -90.83% | -1.16% | 10.36% |
| EBITDA | -113.33% | -38.61% | -91.00% | -1.20% | 10.39% |
| EPS Basic | 63.57% | 60.23% | -74.40% | 21.36% | -45.76% |
| Normalized Basic EPS | 62.07% | 61.48% | -42.57% | 0.93% | -37.25% |
| EPS Diluted | 63.57% | 51.09% | -74.40% | 21.36% | -45.76% |
| Normalized Diluted EPS | 62.07% | 61.48% | -42.57% | 0.93% | -37.25% |
| Average Basic Shares Outstanding | 384.12% | 145.00% | 21.03% | 18.24% | 21.78% |
| Average Diluted Shares Outstanding | 384.12% | 145.00% | 21.03% | 18.24% | 21.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |